Vermeulen Katrien, Strnad Miroslav, Havlícek Libor, Van Onckelen Harry, Lenjou Marc, Nijs Griet, Van Bockstaele Dirk R, Berneman Zwi N
Laboratory of Experimental Hematology, University of Antwerp, Antwerp University Hospital, Edegem, Belgium.
Exp Hematol. 2002 Oct;30(10):1107-14. doi: 10.1016/s0301-472x(02)00894-9.
Regulation of the cell cycle by cyclin-dependent kinase (CDK) activity occurs at multiple levels and is often altered in human cancers. Therefore, CDK activity has been targeted for drug discovery, and a number of small molecules have now been identified as CDK inhibitors. Plant cytokinin analogues with CDK inhibitory activity and antiproliferative effects were studied to characterize the cellular basis of the cytotoxic effect.
The IC(50) value (concentration at which 50% of the cell proliferation is inhibited) and AC(50) value (concentration at which 50% of the cell population is apoptotic) were determined by flow cytometry and microscopy, respectively. A new multiparametric flow cytometric analysis was used to study the sequence of different apoptotic events. In this assay, analysis of phosphatidylserine exposure, mitochondrial membrane depolarization, activation of caspases and DNA condensation were combined.
Treatment of Jurkat and KG1 cells with the CDK inhibitors results in a decrease of viable cells and a parallel increase in percentage of apoptotic cells. Apoptosis was accompanied by a rapid decrease of mitochondrial membrane potential, which precedes DNA condensation, exposure of phosphatidylserine and activation of caspases.
The main cellular mechanism of the antiproliferative effect of plant cytokinin analogues with CDK inhibitory activity is the induction of apoptosis. The multiparametric flow cytometric technique allowed to follow the kinetics of various aspects of apoptotic cell changes and demonstrated that cytokinin analogue-induced apoptosis starts through the mitochondrial pathway. This technique could also become of value for the rapid screening of pro-apoptotic properties of chemotherapeutic compounds.
细胞周期蛋白依赖性激酶(CDK)活性对细胞周期的调控发生在多个层面,且在人类癌症中常发生改变。因此,CDK活性已成为药物研发的靶点,目前已鉴定出多种小分子作为CDK抑制剂。对具有CDK抑制活性和抗增殖作用的植物细胞分裂素类似物进行了研究,以表征其细胞毒性作用的细胞基础。
分别通过流式细胞术和显微镜测定IC(50)值(抑制50%细胞增殖的浓度)和AC(50)值(使50%细胞群体凋亡的浓度)。采用一种新的多参数流式细胞术分析方法研究不同凋亡事件的顺序。在该分析中,将磷脂酰丝氨酸暴露、线粒体膜去极化、半胱天冬酶激活和DNA凝聚的分析结合起来。
用CDK抑制剂处理Jurkat和KG1细胞导致活细胞数量减少,凋亡细胞百分比相应增加。凋亡伴随着线粒体膜电位的快速下降,这发生在DNA凝聚、磷脂酰丝氨酸暴露和半胱天冬酶激活之前。
具有CDK抑制活性的植物细胞分裂素类似物抗增殖作用的主要细胞机制是诱导凋亡。多参数流式细胞术能够追踪凋亡细胞变化各个方面的动力学,并证明细胞分裂素类似物诱导的凋亡通过线粒体途径启动。该技术对于快速筛选化疗化合物的促凋亡特性也可能具有价值。